ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,211
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, Phase 1/2 trial
Author(s):
P. SHARMA
,
MK Callahan
,
P Bono
,
P Sharma
,
MK CALLAHAN
Publication date:
2016
Journal:
Lancet Oncol.
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Herbal Medicines Journal (Herb Med J)
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
1,211
PTU-032 Management of autoimmune hepatitis: a UK-wide survey
Authors:
H Dhaliwal
,
C Facey
,
D. GLEESON
Nivolumab ± ipilimumab in pts with advanced (adv)/metastatic chemotherapy-refractory (CTx-R) gastric (G), esophageal (E), or gastroesophageal junction (GEJ) cancer: CheckMate 032 study [abstract]
Authors:
YY Janjigian
,
PA Ott
,
E. CALVO
…
Nivolumab monotherapy in patients with advanced gastric or gastroesophageal junction (GEJ) cancer and 2 or more prior treatment regimens: Sub-analysis of the CheckMate 032 study
Authors:
Patrick Ott
,
Emiliano Calvo
,
Padmanee Sharma
…
See all similar